November, 2022 (2)

• A Retrospective Cohort Study of Women and Men Living with HIV, Attending an HIV Clinic in Australia.
  Hamilton RA, Wells Y, Higgs P
  Womens Health Rep (New Rochelle). 2022 Nov; 3(1):915-923
• Left behind on the path to 90-90-90: understanding and responding to HIV among displaced people.
  Vasylyeva TI, Horyniak D, Bojorquez I, Pham MD
  J Int AIDS Soc. 2022 Nov; 25(11):e26031

September, 2022 (2)

• Non-Human Primate Models of HIV Brain Infection and Cognitive Disorders.
  Byrnes SJ, Angelovich TA, Busman-Sahay K, Cochrane CR, Roche M, Estes JD, Churchill MJ
  Viruses. 2022 Sep; 14(9):1997
• Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models.
  Bershteyn A, Jamieson L, Kim HY, Platais I, Milali MP, Mudimu E, Ten Brink D, Martin-Hughes R, Kelly SL, Phillips AN, Bansi-Matharu L, Cambiano V, Revill P, Meyer-Rath G, Nichols BE
  Lancet Glob Health. 2022 Sep; 10(9):e1298-e1306

August, 2022 (1)

• "How PrEPared are you?": Knowledge of and attitudes toward PrEP among overseas-born and newly arrived gay, bisexual, and other men who have sex with men in Australia.
  Sudarto B, Chow EPF, Medland N, Fairley CK, Wright EJ, Armishaw J, Price B, Phillips TR, Ong JJ
  Front Public Health. 2022 Aug; 10:946771

July, 2022 (2)

• Intact HIV proviruses persist in the brain despite viral suppression with ART.
  Cochrane CR, Angelovich TA, Byrnes SJ, Waring E, Guanizo AC, Trollope GS, Zhou J, Vue J, Senior L, Wanicek E, Jamal Eddine J, Gartner MJ, Jenkins TA, Gorry PR, Brew BJ, Lewin SR, Estes JD, Roche M, Churchill MJ
  Ann Neurol. 2022 Jul; 92(4):532-544
• The acceptability and usability of two HIV self-test kits among men who have sex with men: a randomised crossover trial.
  Lee DY, Ong JJ, Smith K, Jamil MS, McIver R, Wigan R, Maddaford K, McNulty A, Kaldor JM, Fairley CK, Bavinton B, Chen M, Chow EP, Grulich AE, Holt M, Conway DP, Stoové M, Wand H, Guy RJ
  Med J Aust. 2022 Jul; 217(3):149-154

June, 2022 (3)

• Elevated CD4+ T cell glucose metabolism in HIV+ women with diabetes mellitus.
  Butterfield TR, Hanna DB, Kaplan RC, Xue X, Kizer JR, Durkin HG, Kassaye SG, Nowicki M, Tien PC, Golub ET, Floris-Moore MA, Titanji K, Fischl MA, Heath S, Palmer CS, Landay AL, Anzinger JJ
  AIDS. 2022 Jun; 36(10):1327-1336
• Viral load monitoring for people living with HIV in the era of test and treat: progress made and challenges ahead - a systematic review.
  Pham MD, Nguyen HV, Anderson D, Crowe S, Luchters S
  BMC Public Health. 2022 Jun; 22(1):1203
• Prevalence, socio-demographics and service use determinants associated with disclosure of HIV/AIDS status to infected children: a systematic review and meta-analysis by 1985-2021.
  Armoon B, Fleury MJ, Higgs P, Bayat AH, Bayani A, Mohammadi R, Ahounbar E.
  Arch Public Health. 2022 Jun; 80(1):154

May, 2022 (4)

• Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study.
  Ten Brink DC, Martin-Hughes R, Minnery ME, Osborne AJ, Schmidt HA, Dalal S, Green KE, Ramaurtarsing R, Wilson DP, Kelly SL
  PLoS One. 2022 May; 17(5):e0268240
• Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
  Traeger MW, Guy R, Asselin J, Patel P, Carter A, Wright EJ, Grulich A, McManus H, Fairley CK, Chow EPF, McNulty A, Finlayson R, Bell C, Owen L, Marshall L, Russell D, O'Donnell D, Donovan B, Hellard ME, Stoové MA; Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS) Study Group.
  Lancet Infect Dis. 2022 May; 22(8):1231-1241
• HIV pre-exposure prophylaxis uptake and continuation among key populations in Cameroon: Lessons learned from the CHAMP program.
  Ndenkeh JN, Bowring AL, Njindam IM, Folem RD, Hendji Fako GC, Ngueguim FG, Gayou OL, Lepawa K, Minka CM, Batoum CM, Georges S, Temgoua E, Nzima V, Kob DA, Akiy ZZ, Philbrick W, Levitt D, Curry D, Baral S
  J Acquir Immune Defic Syndr. 2022 May; 91(1):39-46
• Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
  Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G, Hallett TB, Ten Brink D, Kelly SL, Nichols BE, Bendavid E, Mudimu E, Taramusi I, Smith J, Dalal S, Baggaley R, Crowley S, Terris-Prestholt F, Godfrey-Faussett P, Mukui I, Jahn A, Case KK, Havlir D, Petersen M, Kamya M, Koss CA, Balzer LB, Apollo T, Chidarikire T, Mellors JW, Parikh UM, Godfrey C, Cambiano V; HIV Modelling Consortium.
  Lancet HIV. 2022 May; 9(5):e353-e362

April, 2022 (2)

• Antiretroviral initiation at >/=800 CD4+ cells/mm3 associated with lower HIV reservoir size.
  Rasmussen TA, Ahuja SK, Kuwanda L, Vjecha MJ, Hudson F, Lal L, Rhodes A, Chang J, Palmer S, Auberson-Munderi P, Mugerwa H, Wood R, Badal-Faesen S, Pillay S, Mngqibisa R, LaRosa A, Hildago J, Petoumenos K, Chiu C, Lutaakome J, Kitonsa J, Kabaswaga E, Pala P, Ganoza C, Fisher K, Chang C, Lewin SR, Wright EJ
  Clin Infect Dis. 2022 Apr; 75(10):1781-1791
• Perspectives on the use of modelling and economic analysis to guide HIV programmes in sub-Saharan Africa.
  Modelling to Inform HIV Programmes in sub-Saharan Africa (MIHPSA) Working Group (including Kerr CC)
  Lancet HIV. 2022 Apr; 9(7):e517-e520

March, 2022 (3)

• Barriers to accessing HIV pre-exposure prophylaxis for Medicare-ineligible people in Melbourne, Australia: analysis of patients attending the PrEPMe Clinic.
  Cornelisse VJ, Armishaw J, Catton M, Murphy D, Wright EJ
  Med J Aust. 2022 Mar; 216(6):320-321
• Perspectives of health and community stakeholders on community-delivered models of malaria elimination in Lao People's Democratic Republic: A qualitative study.
  Oo MC, Phongluxa K, Oo WH, Kounnavong S, Xayyavong S, Louangphaxay C, Htike W, Cutts JC, Thu KM, Hkawng GN, Fowkes FJI
  PLoS One. 2022 Mar; 17(3):e0264399
• A profile of the Visitect(R) CD4 and Visitect(R) CD4 advanced disease for management of people living with HIV.
  Pham MD, Stoove M, Crowe S, Luchters S, Anderson D`
  Expert Rev Mol Diagn. 2022 Mar; 22(3):247-252

January, 2022 (1)

• A summary of the sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment.
  Sherrill-Mix S, Yang M, Aldrovandi GM, Brenchley J, Bushman F, Collman R, Dandekar S, Klatt NR, Lagenaur LA, Landay A, Paredes R, Tachedjian G, Turpin JA, Serrano-Villar S, Lozupone C, Ghosh M
  AIDS Res Hum Retroviruses. 2022 Jan; 38(3):173-180